Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

Because institutional funds largely can’t own ELTP shares while it is a penny stock.

Because a chunk of brokerages won’t let you trade ELTP at all.

Because the company pivoted from its original abuse deterrent goal and probably scared off some would-be investors from a few rounds of overpromising and under delivering.

Because Elite had to dilute its shares to stay in business and continue funding new drugs, which drags on price.

Because stocks of all calibers go through periods of simply being undervalued or overvalued irrespective of fundamentals.

Because certain individuals admit to having engaged in shorting campaigns on Elite, which drags on price.

Because we’re on the OTC and during periods of extremely low volume, market makers will play games, which drags on price.

We have multiple drugs in the pipeline, plus already approved, that equal several billion dollars in market size. Nasrat is not going to sell the company for not even a double in share price from here when they’ve had independent valuations for over $1 years ago. Seriously, give it a rest.

Doesn’t matter what your personal price target is - it isn’t going to happen.